Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Nestor Toapanta x
  • Refine by Content Type: All x
Clear All Modify Search
Nestor Toapanta and María José Soler

Chronic kidney disease is one of the risk factors that has been associated with higher risk of infection and mortality from SARS-CoV-2 (1, 2). The increased rate of SARS-CoV-2 infection has been related to the transportation and greater hospital exposure of patients (3, 4). In addition, the higher mortality rate has been, in part, ascribed to alterations in the immune system.

Vaccination against SARS-CoV-2 infection has raised hopes for the pandemic to end. Recent studies reported that the BNT162b2 (Pfizer-BioNTech) vaccine against SARS-CoV-2 is effective for symptomatic COVID-19 in the general population,